Title: Therapeutic Interventions in the Complement System
Abstract: Complement as a Regulatory and Effector Pathway in Human Diseases, V. Michael Holers. The Regulation of C1 Activation and its Role in Disease, C. Erik Hack. Inhibition of Complement Serine Proteases as a Therapeutic Strategy, Sthanam V.L. Narayana, Y. Sudhakara Babu, and John E. Volanakis. Complement Inhibitors Targeting C3, C4, and C5, Arvind Sahu, Dimitrios Morikis, and John D. Lambris. Complement Anaphylatoxins (C3a, C4a, C5a) and Their Receptors (C3aR, C5aR/CD88) as Therapeutic Targets in Inflammation, Rick A. Wetsel, Jens Kildsgaard, and David L. Haviland. Modulation of Disease Using Recombinant Human Endogenous Complement Inhibitors, Richard J. Quigg. Roles of the Integrins CR3 and CR4 in Disease and Therapeutic Strategies, Yu Xia and Gordon D. Ross. Inhibition of Complement at the Membrane Attack Pathway, B. Paul Morgan. Evaluation of Complement Inhibitors, Patricia C. Giclas. Use of Animal Models to Define Complement Functions, Peter A. Ward, Boris J. Czermak, Markus Huber-Lang, Katherine Diehl, and Hans P. Friedl.
Publication Year: 2000
Publication Date: 2000-04-15
Language: en
Type: book
Indexed In: ['crossref']
Access and Citation
Cited By Count: 95
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot